Gradient Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-314
| Closed | -$11.6K | – | 1480 |
|
|
2023
Q4 | $11.6K | Sell |
314
-48
| -13% | -$1.72K | ﹤0.01% | 811 |
|
|
2023
Q3 | $13.1K | Buy |
362
+29
| +9% | +$1.03K | ﹤0.01% | 755 |
|
|
2023
Q2 | $11.9K | Buy |
333
+41
| +14% | +$1.47K | ﹤0.01% | 780 |
|
|
2023
Q1 | $10.4K | Sell |
292
-16
| -5% | -$560 | ﹤0.01% | 806 |
|
|
2022
Q4 | $10.8K | Buy |
308
+16
| +5% | +$533 | ﹤0.01% | 793 |
|
|
2022
Q3 | $9K | Sell |
292
-2
| -0.7% | -$76 | ﹤0.01% | 820 |
|
|
2022
Q2 | $16K | Sell |
294
-80
| -21% | -$4.42K | ﹤0.01% | 684 |
|
|
2022
Q1 | $20K | Sell |
374
-338
| -47% | -$18.4K | ﹤0.01% | 650 |
|
|
2021
Q4 | $39K | Hold |
712
| – | – | ﹤0.01% | 521 |
|
|
2021
Q3 | $34K | Buy |
712
+122
| +21% | +$6.13K | ﹤0.01% | 534 |
|
|
2021
Q2 | $29K | Sell |
590
-334
| -36% | -$16K | ﹤0.01% | 568 |
|
|
2021
Q1 | $41K | Buy |
924
+160
| +21% | +$7.26K | ﹤0.01% | 488 |
|
|
2020
Q4 | $36K | Hold |
764
| – | – | ﹤0.01% | 458 |
|
|
2020
Q3 | $36K | Hold |
764
| – | – | ﹤0.01% | 460 |
|
|
2020
Q2 | $39K | Buy |
764
+6
| +0.8% | +$308 | ﹤0.01% | 423 |
|
|
2020
Q1 | $36K | Buy |
758
+432
| +133% | +$23K | ﹤0.01% | 409 |
|
|
2019
Q4 | $19K | Sell |
326
-655
| -67% | -$36.4K | ﹤0.01% | 572 |
|
|
2019
Q3 | $52K | Buy |
981
+646
| +193% | +$33.2K | ﹤0.01% | 384 |
|
|
2019
Q2 | $17K | Sell |
335
-19
| -5% | -$953 | ﹤0.01% | 537 |
|
|
2019
Q1 | $19K | Buy |
354
+28
| +9% | +$1.4K | ﹤0.01% | 455 |
|
|
2018
Q4 | $16K | Buy |
326
+60
| +23% | +$2.96K | ﹤0.01% | 489 |
|
|
2018
Q3 | $13K | Buy |
266
+20
| +8% | +$1.02K | ﹤0.01% | 578 |
|
|
2018
Q2 | $12K | Hold |
246
| – | – | ﹤0.01% | 575 |
|
|
2018
Q1 | $12K | Hold |
246
| – | – | ﹤0.01% | 591 |
|
|
2017
Q4 | $11K | Buy |
+246
| New | +$11.4K | ﹤0.01% | 577 |
|
|
2017
Q3 | – | Sell |
-189
| Closed | -$10K | – | 422 |
|
|
2017
Q2 | $10K | Sell |
189
-161
| -46% | -$8.58K | ﹤0.01% | 481 |
|
|
2017
Q1 | $18K | Sell |
350
-450
| -56% | -$22.8K | ﹤0.01% | 422 |
|
|
2016
Q4 | $39K | Buy |
+800
| New | +$39.5K | ﹤0.01% | 288 |
|
|
2016
Q1 | – | Sell |
-80
| Closed | -$4K | – | 753 |
|
|
2015
Q4 | $4K | Hold |
80
| – | – | ﹤0.01% | 518 |
|
|
2015
Q3 | $4K | Hold |
80
| – | – | ﹤0.01% | 473 |
|
|
2015
Q2 | $4K | Hold |
80
| – | – | ﹤0.01% | 483 |
|
|
2015
Q1 | $5K | Hold |
80
| – | – | ﹤0.01% | 481 |
|
|
2014
Q4 | $4K | Hold |
80
| – | – | ﹤0.01% | 431 |
|
|
2014
Q3 | $5K | Sell |
80
-35,114
| -100% | -$2.15M | ﹤0.01% | 377 |
|
|
2014
Q2 | $2.35M | Buy |
35,194
+35,069
| +28,055% | +$2.37M | 0.46% | 73 |
|
|
2014
Q1 | $8K | Buy |
125
+45
| +56% | +$3.04K | ﹤0.01% | 359 |
|
|
2013
Q4 | $5K | Sell |
80
-42
| -34% | -$2.72K | ﹤0.01% | 433 |
|
|
2013
Q3 | $8K | Buy |
+122
| New | +$7.85K | ﹤0.01% | 304 |
|
Other funds holding GSK
JEST
Gradient Investments's GSK Position: Q1 2024 in Review
Gradient Investments sold out of GSK (GSK) in Q1 2024, closing a stake of 314 shares — an estimated $11.6K sold.
Gradient Investments first reported a position in GSK in Q3 2013 and held it in 38 quarters. The position peaked at $2.35M in Q2 2014. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.
- Gradient Investments reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
- Gradient Investments sold 314 GSK shares in Q1 2024, an estimated $11.6K.
- Gradient Investments first reported a position in GSK in Q3 2013 and held it in 38 quarters.
- Gradient Investments's GSK position peaked at $2.35M in Q2 2014.
- 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.
Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.